Scientific program
{}
PROGRAM
Wednesday, October 1, 2025
| 11:00 | Participant’s welcome |
|---|---|
| 12:30-14:00 | Lunch |
| 14:00-14:30 | Opening of the conference Prof. Sylvie Crauste-Manciet - President GERPAC/ESHPT (Angers - France) |
| 14:30-15:30 | Pharmaceutical issues and compounding in New Zealand for paedriatrics Dr Elisabeth Oliphant (University of Auckland - New Zealand) |
| 15:30-16:00 | Eco-Conception in pharmaceutical technologies Prof. Valérie Sautou (Clermont-Ferrand - France) |
| 16:00-17:00 | Break coffee - Exhibition visit |
| 17:00-18:00 | Short oral communications (1) |
| Feasibility study of an oral formulation of pyridoxine in the treatment of pharmacoresistant epilepsies L. Pacqueu (CHU Lille – FR) | |
| Integrating an automated compounding system into an isolator: the relevance of microbiological requalification C. Dréano (CHU Angers - FR) | |
| Evaluating microbial viability differently: impedance cytometry versus culture A-C. Joly (Hôpital Saint-Antoine, APHP, Paris - FR) | |
| Assessment of a fun training course on Good Manufacturing Practice for pharmacy technicians: feedback on the use of the BPP Quiz® B. Dessane (CHU Poitiers - FR) | |
| French national external quality assessment campaign for parenteral nutrition controls E. Kaczmar (CHU Grenoble - FR) | |
| Formulation of a Cyclodextrin-Based Ophthalmic Drug Solution of Chlorhexidine for the treatment of Acanthamoeba F. Marçon (CHU Amiens - FR) | |
| 18:00-19:00 | Concurrent e-posters flash communications |
| Session A: Quality Assurance, Risk Analysis and CSR | |
| Session B: Feasibility studies - Formulations | |
| Session C: Stability studies and quality control | |
| Session D: Production and automation processes | |
| Session E: Analytical and microbiological techniques |
Thursday, October 2, 2025
| 08:30-10:00 | Toward standardisation: Parenteral Nutrition in neonatology Southern Pacific Approach: Dr Elizabeth Oliphant (University of Auckland - New Zealand) Dr Srinivas BOLISETTY (Royal Hospital for Women - Sydney - Australia) French National Approach: Dr Thierry Quessada (Lyon - France) ROUND TABLE: Dr Thierry Quessada (Lyon - France) Dr Martine Bouley (Saint Denis - France) Dr Elizabeth Oliphant (Auckland - New Zealand) |
| 10:00-10:30 | News from European working groups Real’HOPE project Dr Mattias PAULSSON (Uppsala Univ Hospital - SE) GERPAC Special Interest Groups Dr Paul Le Brun (The Hague - Netherlands) Prof Irene Krämer (Mainz - Germany) |
| 10:30-11:30 | Break coffee - Exhibition visit |
| 11:30-13:00 | Concurrent workshops |
| Workshop 1: EU Guidance for safe management of hazardous medicinal products at work Dr Paul Sessink (exposure control, Bjökö - Sweden) Dr Birgit Tans (UZ Leuven - Belgium) | |
| Workshop 2: Managing Extractables and Leachables in Hospital Pharmacy Practices: Challenges and Insights Dr Philip Chennell (Clermont-Ferrand - France) Dr Laurent Carrez, Dr William Bello (Lausanne - Switzerland) | |
| Workshop 3: Microbiological environmental monitoring Dr Frédéric Marçon (Amiens - France) Dr Thomas Storme (Vannes - France) | |
| Workshop 4: Designing a centralized cytotoxic unit to lower RSI (repetitive strain injuries) Dr Anne Brouard-Le Bihan, Virginie Charbonneau, Jérémie Gautreau (Lorient - France), Dr Laurence Escalup (Paris - France), Dr Marie-Noëlle Guerrault-Moro (Poissy-St Germain - France) | |
| Workshop 5: Training in the management of cytotoxic breakage through simulation: a team challenge Dr Alexandra Garnier / Dr Lucie Bouchoud (Geneva - Switzerland) | |
| 13:00-14:30 | Lunch |
| 14:30-15:30 | Short oral communications (2) |
| Can we limit our impact on the planet while producing chemotherapies ? A. Narwa (IUCT Oncopole, Toulouse - FR) | |
| What is the future of Fused Deposition Modeling 3D printing in hospital pharmacies for the production of oral solid dosage forms ? A. Lechanteur (CHU Liège – BE) | |
| Evaluation of the impact of formulations and preparation conditions of reconstituted pemetrexed (PEME) specialties on its stability in infusion bags L. Nobilet (Hôpital Pitié-Salpêtrière, APHP, Paris – FR) | |
| Licensed ready-to-use gemcitabine bags cut carbon emissions versus in-house vial compounding D. Protzenko (CH Gap – FR) | |
| Polyethersulfone in-line filters: an extractible study in the context of chemotherapy administration A. Hassan (CHU Clermont-Ferrand – FR) | |
| One-year assessment of microbiological and particulate environnemental monitoring of equipment in a new radiopharmaceutical compounding unit J. Le Galloudec (CHU Martinique – FR) | |
| 15:30-16:30 | Artificial Intelligence (AI) in Hospital Pharmacy and its applications to pharmaceutical manufacturing What Is It Really? Dr Aziza Merzouki (Geneva - Switzerland) Overview of AI in Hospital Pharmacy: Prof Frédéric Lagarce (Angers - France) Dr Frédéric Marçon (Amiens - France) Prof Farshid Sadeghipour (Lausanne - Switzerland) Dr Guillaume Galy (Lausanne - Switzerland) |
| 16:30-17:30 | Break coffee - Exhibition visit |
| 17:30-18:00 | Pharmaceutical Technology Master Awards |
| 18:00-19:00 | Short oral communications (3) |
| Feasibility study of a cardioplegia solution using the Del Nido formulation L. Métreau (Hôpital Necker-Enfants Malades, Paris - FR) | |
| An innovative formulation of Cyclophosphamide chewable gummies, produced using 3D Printing, for pediatric administration M. Boucida (IGR Paris – FR) | |
| Mapping of sterile anticancer drug preparations in hospital pharmacies in Nouvelle-Aquitaine: current status, territorial disparities and opportunities for cooperation coopération N. Hami (CHU Bordeaux – FR) | |
| Analytical control of anticancer agents via sample-free near infrared spectroscopy : first feedback J. Evrard (CH Arras – FR) | |
| Development of a method for the quantification of bacterial endotoxins in parenteral vitamin-lipid emulsion preparations using the recombinant C factor J. Claves (CHU Clermont-Ferrand – FR) | |
| Surface Contamination in 127 Canadian Hospitals: Results from the 2025 Surveillance Program M. Elluard (CHU Sainte-Justine, Montréal - CA) | |
| 19:00-20:00 | GERPAC GENERAL ASSEMBLY for members only |
Friday, October 3, 2025
| 09:00-10:00 | Short oral communications (4) |
|---|---|
| New openable softgel use in oral: need for suitable forms in pediatrics and proof of concept B. Dessane (CHU Poitiers - FR) | |
| Evaluation of In-Use Physicochemical Stability of Diluted Isatuximab (ISA) H. Sadou Yayé (Hôpital Pitié-Salpêtrière, APHP, Paris – FR) | |
| Analytical control of anticancer agents via sample-free near infrared spectroscopy: first feedback J. Evrard (CH Arras – FR) | |
| Low-temperature sterilization of Novelia® eye drops vials: feasibility, content-container interactions and functional impact M. Ben Reguiga (CH Mayotte - FR) | |
| Techno-Economic Comparison Between Semi-Solid Extrusion 3D Printing of Oral Forms and Capsule Compounding in a Hospital Setting L. Lemierre (ICGM Université de Montpellier - FR) | |
| Development of fenfluramine in albumin nanoparticles for nasal administration M. Petit (CHU Strasbourg – FR) | |
| 10:00-11:00 | Break coffee - Exhibition visit |
| 11:00-12:00 | Interactive case studies Interactive session dedicated to professional exchanges Facilitators: Prof Farshid Sadeghipour (Lausanne - Switzerland) Dr Thomas Storme (Vannes - France) |
| 12:00-12:15 | Award ceremony - Conclusion |
| 12:15 | Lunch |